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Abstract
Gastrointestinal mucormycosis is an uncommon, invasive, opportunistic fungal infection with a high mortality rate, seen
more commonly in immunocompromised patients. This lethal infection has a wide range of presentations, from colonization of peptic ulcers to infiltrative disease and eventually vascular invasion. Here we present a case of upper gastrointestinal
bleeding in an immunocompromised patient, which was proved to be secondary to gastric involvement by mucormycosis.
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Introduction
Gastrointestinal mucormycosis is an uncommon and invasive,
opportunistic fungal infection with a high mortality rate,
seen more commonly in immunocompromised patients [1].
All portions of the gastrointestinal tract can become involved,
with the stomach being the most common site [2]. This
lethal infection has a wide range of presentations, from colonization of peptic ulcers to infiltrative disease and eventually vascular invasion. Here we present a case of upper
gastrointestinal bleeding in an immunocompromised patient
which was proved to be secondary to gastric involvement by
mucormycosis.

Case presentation
A 65-year-old male with type 2 diabetes, interstitial lung disease and rheumatoid arthritis—the latter being treated with

chronic prednisone therapy and leflunomide—presented with
periumblical abdominal pain and dark, tarry stool for the previous 24 hours. Laboratory testing demonstrated a drop in hemoglobin from 13.0 to 6.7 g/dL.
A large mass was found on contrast-enhanced computed tomography (CT), extending from the esophago-gastric junction
to the mid-gastric body and containing extensive infiltrative
gas (Figure 1). Esophago-gastroduodenoscopy revealed a large,
infiltrative mass with infiltration into the surrounding gastric
mucosa, characterized by dusky, necrotic and ulcerative mucosa with multiple clots (Figure 2). Biopsies were taken and
revealed broad, ribbon-like fungal elements infiltrating the
gastric parenchyma, compatible with mucormycosis (Figure 3).
Lactophenol cotton blue adhesive tape preparation from colony,
showed sporangiophores directly over the sporangium, compatible with rhizopus (Figure 4).
The patient proceeded to surgery for sub-total gastrectomy
with Roux-en-Y esophagojejunostomy.
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inflammation with broad, ribbon-like fungal elements infiltrating the gastric
parenchyma
Figure 1. Post-contrast axial CT of the abdomen at the level of the gastric body
reveals a large, loculated mass with a large amount of gas bubbles occupying
most of the gastric body and fundus

Figure 4. Lactophenol cotton blue adhesive tape preparation from colony shows
sporangiophores directly over the sporangium, consistent with rhizopus

Figure 2. Esophago-gastroduodenoscopy shows a large fungating mass starting
at the esophago-gastric junction and extending inferiorly, with obscured landmarks and dusky, ulcerated and necrotic mucosa

Discussion
Gastrointestinal mucormycosis is an uncommon and invasive
opportunistic fungal infection with a high mortality rate,
seen more commonly in immunocompromised patients [1].
Some of the common risk factors for this infection include
diabetes, inherited immunodeficiencies, immunosuppressants,
solid organ- and hematopoietic stem cell transplant, malnutrition, and hematological malignancies, such as lymphoma
and leukemia [2]. A meta-analysis of 929 cases revealed that
the site of infection varies according to the underlying predisposing factor, with the paranasal sinuses being the most
common site (39%, compared with 7% in the gastrointestinal
tract) [3]. All portions of the gastrointestinal tract can
become involved, with the stomach being the most common
site [4].

This lethal infection has a wide range of presentations, from
colonization of peptic ulcers to infiltrative disease and eventually vascular invasion. Invasion of the vessels by this fungus
causes thrombosis, infraction and tissue necrosis, which can
present as gastrointestinal bleeding [1, 4]. The mortality rate
from gastrointestinal mucor infection is up to 85%,
which makes early diagnosis crucial [3]. Patients should be diagnosed based on their histological findings, since the culture is
positive in only 30% of surgical specimens [5]. Treatment is a
combination of early surgical debridement of infected tissue,
along with systemic antifungal therapy (usually parenteral amphotericin B at 1 mg/kg/day or oral posaconazole at 400 mg,
given twice daily) [1, 6, 7]. Early intervention with a combined
approach will give the patient a better chance of survival, up to
70% [3].
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Figure 3. A hematoxylin & eosin section from the stomach reveals suppurative
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